We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current APDNW market cap is 10.93k. The company's latest EPS is USD -0.7283 and P/E is -0.62.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 4.41M | 2.92M | 779k | 891k | 930k |
| Operating Income | -2.7M | -2.86M | -4.17M | -3.79M | -3.62M |
| Net Income | 588k | -3.2M | -3.49M | -1.11M | -4.7M |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 5.39M | 1.93M | 9.03M | 18.17M | 13.37M |
| Operating Income | -9.12M | -12.54M | -13.11M | -13.97M | -10.95M |
| Net Income | -8.93M | -13.03M | -14.29M | -8.27M | -9.95M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 19.18M | 15.79M | 13.65M | 9.91M | 9.18M |
| Total Liabilities | 9.21M | 8.6M | 8.78M | 5.79M | 9.35M |
| Total Equity | 9.97M | 7.19M | 4.87M | 4.13M | -175k |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.57M | 11.34M | 14.42M | 22.27M | 13.65M |
| Total Liabilities | 4.41M | 5.63M | 3.3M | 9.36M | 8.78M |
| Total Equity | -848k | 5.71M | 11.11M | 12.91M | 4.87M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.17M | -3.54M | -6.22M | -3.76M | -6.97M |
| Investing | -9k | -171k | -1.1M | N/A | -15k |
| Financing | N/A | N/A | N/A | -35k | 2.98M |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.86M | -11.14M | -13.39M | -8.98M | -6.22M |
| Investing | -67k | -1.06M | -2.55M | -490k | -1.1M |
| Financing | 5.83M | 19.44M | 14.71M | 18.13M | N/A |
| Market Cap | 10.93k |
| Price to Earnings Ratio | -0.62 |
| Price to Sales Ratio | 0.46 |
| Price to Cash Ratio | 0.86 |
| Price to Book Ratio | 1.26 |
| Dividend Yield | - |
| Shares Outstanding | 13.66M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (82.22%) |
| Company Name | Applied DNA Sciences Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.adnas.com |
| Industry | testing laboratories (8734) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
